Acro Biomedical Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACBM research report →
Price Chart
About the company
Acro Biomedical Co. , Ltd. focuses on the development and commercialization of dietary supplements.
- CEO
- Yu-Ting Su
- IPO
- 2021
- Employees
- 1
- HQ
- Fishers, IN, US
Get TickerSpark's AI analysis on ACBM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.56M
- P/E
- -10.83
- PEG
- 0.11
- P/S
- 0.00
- P/B
- -3.51
- EV/EBITDA
- -9.28
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 33.20%
- ROIC
- 352.35%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-154,024
- Net Income
- $-101,146-139.1%
- EPS
- $-0.00-142.9%
- OCF Growth
- -435.0%
- FCF Growth
- -435.0%
- 52W High
- $0.10
- 52W Low
- $0.00
- 50D MA
- $0.03
- 200D MA
- $0.02
- Beta
- -2.31
- RSI (14)
- 68
- Avg Volume
- 4
No earnings-call transcripts are available for ACBM yet.
- Free Float
- 50.0%
- Shares Outstanding
- 60.04M
- Float Shares
- 30.04M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 31, 20 | Chu Pao-Chi | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ACBM coverage
Recent articles, reports, and earnings notes.
No research on ACBM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ACBM report →